5,443
Participants
Start Date
July 31, 2014
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
Chronic Lymphocytic Leukemia (CLL)
This is observational study. Participants with Chronic Lymphocytic Leukemia (CLL) will be observed for 1 year.
Multiple Myeloma (MM)
This is observational study. Participants with Multiple Myeloma (MM) will be observed for 1 year.
Non-Hodgkin's lymphoma (NHL)
This is observational study. Participants with non-Hodgkin's lymphoma (NHL) will be observed for 1 year.
Buenos Aires
Córdoba
La Plata Lpl Lpl
Belo Horizonte
Fortaleza
Goiânia
Porto Alegre
São José do Rio Preto
São Paulo
Santiago
Bogotá
Bogotá Dc
Floridablanca
Medellín
Santiago de Cali
Guatemala City
Huixquilucan
Mexico City
México
Monterrey
Toluca
Panama City
Panama Republic Panama
Janssen-Cilag Ltd.
INDUSTRY